KMDA Q4 2019 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena

KMDAKamada Ltd.

$495M

Q4 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$32M-33.5% YoY

Gross Profit

$12M37.7% margin

Operating Income

$5M17.1% margin

Net Income

$5M16.7% margin

EPS (Diluted)

$0.13

QoQ Revenue Growth

-3.0%

Cash Flow

Operating Cash Flow

$9M

Free Cash Flow

$8M

Stock-Based Comp.

$176,000

Balance Sheet

Total Assets

$174M

Total Liabilities

$38M

Stockholders' Equity

$135M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$32M	$48M	-33.5%
Gross Profit	$12M	$21M	-43.1%
Operating Income	$5M	$15M	-64.3%
Net Income	$5M	$18M	-69.8%